664 related articles for article (PubMed ID: 9673147)
1. Tuberculin skin test and chemoprophylaxis of tuberculosis.
Ortona L; Fantoni M
Rays; 1998; 23(1):218-24. PubMed ID: 9673147
[TBL] [Abstract][Full Text] [Related]
2. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.
Alaei K; Alaei A; Mansouri D
East Mediterr Health J; 2002 Nov; 8(6):754-7. PubMed ID: 15568452
[TBL] [Abstract][Full Text] [Related]
3. Positive PPD and chemoprophylaxis for tuberculosis infection.
Pickwell SM
Am Fam Physician; 1995 Jun; 51(8):1929-34, 1937-8. PubMed ID: 7762484
[TBL] [Abstract][Full Text] [Related]
4. [The role of chemoprophylaxis in prevention of tuberculosis].
Jovanović D
Med Pregl; 2004; 57 Suppl 1():49-52. PubMed ID: 15686222
[TBL] [Abstract][Full Text] [Related]
5. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
6. Missed opportunities for prevention of tuberculosis among persons with HIV infection--selected locations, United States, 1996-1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Aug; 49(30):685-7. PubMed ID: 10947056
[TBL] [Abstract][Full Text] [Related]
7. Presumptive TB prophylaxis rejected.
Torres G
GMHC Treat Issues; 1997 Oct; 11(10):5-6. PubMed ID: 11364822
[TBL] [Abstract][Full Text] [Related]
8. [Tuberculin test, antitubercular chemoprophylaxis and incidence of tuberculosis in a Swiss HIV cohort study].
Sudre P; Rieder H; Bassetti S; Hirschel B; Ledergerber B; Malvy D
Rev Epidemiol Sante Publique; 1997 Apr; 45(2):171-3. PubMed ID: 9221445
[No Abstract] [Full Text] [Related]
9. [Indications for chemoprophylaxis of tuberculosis. Arguments for].
Nicod LP
Schweiz Med Wochenschr; 1993 Feb; 123(5):154-8. PubMed ID: 8438136
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
[TBL] [Abstract][Full Text] [Related]
11. Preventing tuberculosis among HIV-infected persons: a survey of physicians' knowledge and practices.
DeRiemer K; Daley CL; Reingold AL
Prev Med; 1999 Apr; 28(4):437-44. PubMed ID: 10090874
[TBL] [Abstract][Full Text] [Related]
12. [Latent tuberculosis infection: diagnosis and treatment].
Bendayan D; Raz M; Kramer MR
Harefuah; 2002 Mar; 141(3):233-6, 316. PubMed ID: 11944212
[TBL] [Abstract][Full Text] [Related]
13. [Tuberculosis associated with the human immunodeficiency virus].
Gérard M
Rev Med Brux; 2000 Apr; 21(2):75-83. PubMed ID: 10829599
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
Sterling TR; Brehm WT; Moore RD; Chaisson RE
Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
[TBL] [Abstract][Full Text] [Related]
15. [Primary chemoprevention of tuberculosis in HIV-infected patients in non-industrialized countries].
Anglaret X; Dabis F; Batungwanayo J; Perronne C; Taelman H; Bonard D; Sylla-Koko F; Leroy V; Van de Perre P; Vildé JL; Salamon R
Sante; 1997; 7(2):89-94. PubMed ID: 9273126
[TBL] [Abstract][Full Text] [Related]
16. [Determination of antibodies against A-60 antigen for diagnosis of M. tuberculosis infection. A useful tool for rationalization of chemoprophylaxis in HIV patients].
Blanco JR; Martínez de Artola V; Ibarra V; Rosel L; Gómez-Cadiñanos R; Oteo JA
An Med Interna; 2001 Mar; 18(3):127-31. PubMed ID: 11594176
[TBL] [Abstract][Full Text] [Related]
17. Tuberculin skin test positivity in pediatric allogeneic BMT recipients and donors in Turkey.
Tavil B; Gulhan B; Ozcelik U; Cetin M; Tezcan I; Tuncer M; Uckan D
Pediatr Transplant; 2007 Jun; 11(4):414-8. PubMed ID: 17493222
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
Scholten JN; Driver CR; Munsiff SS; Kaye K; Rubino MA; Gourevitch MN; Trim C; Amofa J; Seewald R; Highley E; Fujiwara PI
Clin Infect Dis; 2003 Dec; 37(12):1686-92. PubMed ID: 14689352
[TBL] [Abstract][Full Text] [Related]
19. [Tuberculosis outbreak in a junior high school in Kochi City--studies on factors relating to extent of tuberculosis infection and the efficacy of isoniazid chemoprophylaxis].
Toyota M; Morioka S
Kekkaku; 2001 Sep; 76(9):625-34. PubMed ID: 11676120
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of mycobacterial infections in immunocompromised patients.
Krance MB; Fisher MA
Am Fam Physician; 1996 Nov; 54(6):1981-8, 1991-2. PubMed ID: 8900358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
